Bull case
BWXT would need investors to value it at roughly 87x earnings — about 41x more generous than today's 47x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BWXT stock could go
BWXT would need investors to value it at roughly 87x earnings — about 41x more generous than today's 47x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 65x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 10x multiple contraction could push BWXT down roughly 22% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

BWX Technologies is a specialized nuclear components manufacturer that primarily serves U.S. government defense programs and commercial nuclear power plants. It generates revenue through three main segments: Nuclear Operations Group (~70% of revenue) supplying naval nuclear propulsion systems, Nuclear Power Group (~20%) providing commercial nuclear components, and Nuclear Services Group (~10%) offering nuclear fuel and waste management services. The company's key moat is its exclusive position as the sole manufacturer of naval nuclear reactors for the U.S. Navy—a highly regulated, security-sensitive market with massive barriers to entry.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.02/$0.79 | +29.1% | $764M/$794M | -3.8% |
| Q4 2025 | $1.00/$0.85 | +17.2% | $866M/$793M | +9.2% |
| Q1 2026 | $1.08/$0.89 | +21.2% | $886M/$838M | +5.8% |
| Q2 2026 | $1.12/$0.92 | +21.7% | $860M/$837M | +2.7% |
BWXT beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $110 — implies -49.3% from today's price.
| Metric | BWXT | S&P 500 | Industrials | 5Y Avg BWXT |
|---|---|---|---|---|
| Forward PE | 46.7x | 19.1x+145% | 20.8x+124% | — |
| Trailing PE | 59.9x | 25.2x+138% | 25.9x+131% | 30.0x+100% |
| PEG Ratio | 13.97x | 1.74x+702% | 1.64x+753% | — |
| EV/EBITDA | 49.1x | 15.2x+223% | 13.7x+259% | 22.2x+121% |
| Price/FCF | 66.8x | 21.3x+214% | 21.0x+218% | 60.5x+10% |
| Price/Sales | 6.2x | 3.1x+97% | 1.6x+285% | 3.2x+92% |
| Dividend Yield | 0.47% | 1.87% | 1.25% | 1.19% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBWXT generates $328M in free cash flow at a 9.7% margin — 10.1% ROIC signals a durable competitive advantage.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.6 years to full repayment at current FCF run-rate
* Elevated by buyback-compressed equity — compare ROIC (10.1%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
Approximately 75% of BWXT's revenue comes from the U.S. government, making the company vulnerable to federal budget constraints, debt ceiling issues, and potential government shutdowns. These factors can delay funding and disrupt operations, significantly impacting financial performance.
BWXT's nuclear operations are subject to significant environmental, regulatory, and financial risks, including potential liabilities related to environmental and human health impacts. The handling and disposal of radioactive materials also pose serious risks that could lead to substantial financial repercussions.
Non-compliance with safety and quality requirements imposed by regulatory agencies like the NRC and CNSC could lead to increased oversight, fines, or operational shutdowns. Such outcomes could severely affect BWXT's operational capabilities and financial results.
BWXT relies on a limited number of suppliers for critical materials, making it vulnerable to disruptions from geopolitical tensions, trade barriers, and currency fluctuations. These supply chain issues could lead to increased costs and project delays.
The company is currently facing supply-chain issues and a shortage of skilled workers, which could affect project timelines and increase operational costs. This labor shortage could hinder BWXT's ability to meet demand and execute projects efficiently.
While BWXT manages its debt reasonably well, its net debt to EBITDA ratio indicates that ongoing monitoring is warranted due to potential future balance sheet risks. Any deterioration in financial conditions could impact the company's ability to service its debt.
BWXT's stock has a beta of 1.32, indicating higher volatility compared to the broader market. This increased volatility can lead to significant fluctuations in stock price, affecting investor sentiment and market perception.
The competitiveness of alternative energy sources could adversely affect BWXT's manufacturing facilities. As the market evolves, BWXT may face challenges in maintaining its market position against emerging energy technologies.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
BWXT is the sole supplier of nuclear reactor cores and components for the U.S. Navy, providing a stable and recurring revenue base. This includes contracts for programs like the Columbia-class and Virginia-class submarines, significantly driving its business.
There is a broad demand for nuclear solutions driven by the transition to clean energy and heightened defense priorities. BWXT is well-positioned to benefit from this growth, including the potential for commercial nuclear build-out and the development of small modular reactors (SMRs).
BWXT is targeting expansion in space reactors, small modular reactors, and medical isotopes. The company has been selected for projects like DARPA and NASA's DRACO program to demonstrate nuclear thermal propulsion, diversifying income streams and bolstering future commercial opportunities.
BWXT has demonstrated revenue expansion and strong operating cash flow, with analysts projecting significant increases in revenue and net income through 2027. The company's backlog has grown substantially, providing visibility for future revenue.
BWXT's expertise in nuclear component manufacturing and its highly technical, regulated work create significant barriers to entry for competitors. This positions the company favorably in a niche market.
BWXT is initiating pre-application engagement to build a new high-enriched uranium enrichment facility, tied to a significant government contract. This aims to restore domestic HEU processing capability, further strengthening its market position.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BWX BWXT BWX Technologies, Inc. | $19.7B | 46.7x | +13.5% | 10.2% | Buy | -2.4% |
CW CW Curtiss-Wright Corporation | $27.6B | 49.3x | +11.0% | 13.8% | Buy | -4.6% |
LDO LDOS Leidos Holdings, Inc. | $17.1B | 11.4x | +2.7% | 8.2% | Buy | +51.2% |
CAC CACI CACI International Inc | $11.0B | 17.7x | +9.8% | 5.9% | Buy | +45.3% |
HII HII Huntington Ingalls Industries, Inc. | $12.6B | 18.4x | +4.9% | 4.7% | Hold | +31.4% |
GD GD General Dynamics Corporation | $93.9B | 21.1x | +6.1% | 8.1% | Buy | +17.7% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BWXT returns 0.6% total yield, led by a 0.47% dividend, raised 10 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.27 | — | — | — |
| 2025 | $1.00 | +4.2% | 0.2% | 0.8% |
| 2024 | $0.96 | +4.3% | 0.2% | 1.1% |
| 2023 | $0.92 | +4.5% | 0.1% | 1.3% |
| 2022 | $0.88 | +4.8% | 0.4% | 1.9% |
Common questions answered from live analyst data and company financials.
BWX Technologies, Inc. (BWXT) is rated Buy by Wall Street analysts as of 2026. Of 16 analysts covering the stock, 9 rate it Buy or Strong Buy, 6 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $210, implying -2.4% from the current price of $215. The bear case scenario is $169 and the bull case is $403.
The Wall Street consensus price target for BWXT is $210 based on 16 analyst estimates. The high-end target is $225 (+4.6% from today), and the low-end target is $195 (-9.4%). The base case model target is $301.
BWXT trades at 46.7x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals significantly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BWXT in 2026 are: (1) Government Funding Dependence — Approximately 75% of BWXT's revenue comes from the U. (2) Nuclear Operations Risks — BWXT's nuclear operations are subject to significant environmental, regulatory, and financial risks, including potential liabilities related to environmental and human health impacts. (3) Regulatory Compliance Risks — Non-compliance with safety and quality requirements imposed by regulatory agencies like the NRC and CNSC could lead to increased oversight, fines, or operational shutdowns. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BWXT will report consensus revenue of $3.8B (+13.5% year-over-year) and EPS of $4.41 (+17.7% year-over-year) for the upcoming fiscal year. The following year, analysts project $4.4B in revenue.
A confirmed upcoming earnings date for BWXT is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
BWX Technologies, Inc. (BWXT) generated $328M in free cash flow over the trailing twelve months — a free cash flow margin of 9.7%. BWXT returns capital to shareholders through dividends (0.5% yield) and share repurchases ($30M TTM).